AngioDynamics, Inc.
ANGO
Positions held
Your positionsANGO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $471.60M | Enterprise value | $438.30M | Trailing P/E | — | Forward P/E | -118.04 |
| PEG | 1.41 | Price / book | 2.90 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 6.9% | Earnings growth | — | Gross margin | 55.7% | Operating margin | -9.0% |
| Profit margin | -10.1% | ROE | -19.2% | ROA | -4.7% | Debt / equity | — |
| Current ratio | 2.40 | Free cash flow | $24.19M | Analyst recommendation | none | Mean target | $20.00 |
| 52w high | $16.29 | 52w low | $9.39 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $86.6M | $78.4M | $79.4M | $75.7M | $80.2M | — |
| Op margin | -6.4% | -8.2% | -3.1% | -10.4% | -4.5% | — |
| Net income | -$11.4M | -$8.1M | -$6.3M | -$10.9M | -$6.0M | — |
| Gross margin | 54.0% | 52.9% | 56.4% | 55.3% | 52.7% | — |
| Gross profit | $46.8M | $41.5M | $44.8M | $41.9M | $42.2M | — |
| Operating income | -$5.5M | -$6.4M | -$2.5M | -$7.9M | -$3.6M | — |
- Revenue +10% vs prior quarter ($87M vs $78M).
- Gross margin 54% (was 52.9% prior quarter).
- Operating margin expanded to -6.4%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $320M | $292M | $304M | $339M | — |
| Op margin | -7.0% | -8.2% | -11.1% | -5.5% | — |
| Net income | -$36.7M | -$34.0M | -$184M | -$52.4M | — |
| Gross margin | 54.6% | 53.9% | 50.9% | 51.4% | — |
| Gross profit | $175M | $158M | $155M | $174M | — |
| Operating income | -$22.3M | -$24.1M | -$33.8M | -$18.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · AngioDynamics (ANGO) Q1 2027 Earnings Call Transcript
2026-10-08 · AngioDynamics Inc (ANGO) (Q1 2027) Earnings Call Highlights: MedTech Momentum Drives 6. ...
2026-10-08 · Top Midday Decliners
2026-10-08 · AngioDynamics, Inc. Q1 2027 Earnings Call Summary
2026-10-08 · Why AngioDynamics Crashed Today
2026-10-08 · AngioDynamics Q1 Earnings Call Highlights
2026-10-08 · AngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech Growth
2026-10-08 · AngioDynamics stock slips 4% despite beating estimates on Med Tech growth
2026-10-08 · AngioDynamics Names Eric Honroth as Chief Executive
2026-10-08 · AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates
2026-10-08 · AngioDynamics: Fiscal Q1 Earnings Snapshot
Price (daily)
Full chart · RSI · MACD · patterns